The effect of catechol-O-methyltransferase polymorphism on the levodopa pharmacokinetics after co-administration of single dose of levodopa and entacapone in Parkinsonian patients

被引：0
|
作者：
Wu, RM
Yu, IW
Ho, YF
Kuo, JW
Chern, H
机构：
来源：
MOVEMENT DISORDERS | 2002年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P119
引用
收藏
页码：S50 / S51
页数：2
相关论文
共 50 条
  • [1] EFFECT OF PERIPHERAL CATECHOL-O-METHYLTRANSFERASE INHIBITION ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF LEVODOPA IN PARKINSONIAN-PATIENTS
    NUTT, JG
    WOODWARD, WR
    BECKNER, RM
    STONE, CK
    BERGGREN, K
    CARTER, JH
    GANCHER, ST
    HAMMERSTAD, JP
    GORDIN, A
    [J]. NEUROLOGY, 1994, 44 (05) : 913 - 919
  • [2] Pharmacokinetics of levodopa and effect of catechol-O-methyltransferase inhibitors (COMT)
    de la Parte, JFH
    Hernández, MM
    [J]. NEUROLOGIA, 2002, 17 : 57 - 61
  • [3] Effect of one month's treatment with peripherally acting catechol-O-methyltransferase inhibitor, entacapone, on pharmacokinetics and motor response to levodopa in advanced parkinsonian patients
    Ruottinen, HM
    Rinne, UK
    [J]. CLINICAL NEUROPHARMACOLOGY, 1996, 19 (03) : 222 - 233
  • [4] Effect of Carbidopa Dose on Levodopa Pharmacokinetics With and Without Catechol-O-Methyltransferase Inhibition in Healthy Subjects
    Tuunainen, Johanna
    Sjostedt, Noora
    Vahteristo, Mikko
    Ellmen, Juha
    Kuoppamaki, Mikko
    Rouru, Juha
    Yliperttula, Marjo
    [J]. EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2023, 48 (01) : 23 - 34
  • [5] INHIBITION OF SOLUBLE CATECHOL-O-METHYLTRANSFERASE AND SINGLE-DOSE PHARMACOKINETICS AFTER ORAL AND INTRAVENOUS ADMINISTRATION OF ENTACAPONE
    KERANEN, T
    GORDIN, A
    KARLSSON, M
    KORPELA, K
    PENTIKAINEN, PJ
    RITA, H
    SCHULTZ, E
    SEPPALA, L
    WIKBERG, T
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1994, 46 (02) : 151 - 157
  • [6] Effect of Carbidopa Dose on Levodopa Pharmacokinetics With and Without Catechol-O-Methyltransferase Inhibition in Healthy Subjects
    Johanna Tuunainen
    Noora Sjöstedt
    Mikko Vahteristo
    Juha Ellmén
    Mikko Kuoppamäki
    Juha Rouru
    Marjo Yliperttula
    [J]. European Journal of Drug Metabolism and Pharmacokinetics, 2023, 48 : 23 - 34
  • [7] Opicapone Pharmacokinetics and Effects on Catechol-O-Methyltransferase Activity and Levodopa Pharmacokinetics in Patients With Parkinson Disease Receiving Carbidopa/Levodopa
    LeWitt, Peter
    Liang, Grace S.
    Olanow, C. Warren
    Kieburtz, Karl D.
    Jimenez, Roland
    Olson, Kurt
    Klepitskaya, Olga
    Loewen, Gordon
    [J]. CLINICAL NEUROPHARMACOLOGY, 2023, 46 (02) : 43 - 50
  • [8] CATECHOL-O-METHYLTRANSFERASE INHIBITOR TOLCAPONE PROLONGS LEVODOPA CARBIDOPA ACTION IN PARKINSONIAN-PATIENTS
    ROBERTS, JW
    CORALOCATELLI, G
    BRAVI, D
    AMANTEA, MA
    MOURADIAN, MM
    CHASE, TN
    [J]. NEUROLOGY, 1993, 43 (12) : 2685 - 2688
  • [9] The effect of co-administration of opicapone on the pharmacokinetics of levodopa
    Kamiyama, D.
    Nishikawa, N.
    Oyama, G.
    Hatano, T.
    Hattori, N.
    [J]. MOVEMENT DISORDERS, 2022, 37 : S454 - S454
  • [10] Effect of 3 Single-Dose Regimens of Opicapone on Levodopa Pharmacokinetics, Catechol-O-Methyltransferase Activity and Motor Response in Patients With Parkinson Disease
    Rocha, Jose-Francisco
    Ferreira, Joaquim J.
    Falcao, Amilcar
    Santos, Ana
    Pinto, Roberto
    Nunes, Teresa
    Almeida, Luis
    Soares-da-Silva, Patricio
    [J]. CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2016, 5 (03): : 232 - 240
12345